Alopexx, Inc. (ALPX)

Alopexx Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	0.71	0.71	0.31
Research & Development	0.19	0.19	1.35
Operating Expenses	0.9	0.9	1.67
Operating Income	-0.9	-0.9	-1.67
Interest Expense / Income	-0.05	-0.05	-0.03
Other Expense / Income	0.11	0.11	0.07
Pretax Income	-0.96	-0.96	-1.7
Net Income	-0.96	-0.96	-1.7
Free Cash Flow	-0.28	-0.28	-2.07
EBITDA	-1.01	-1.01	-1.74
EBIT	-1.01	-1.01	-1.74

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).